연구성과로 돌아가기
2024 연구성과별 연구자 정보 (1654 / 2344)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase IB/II trial of durvalumab plus doxorubicin combination in patients with advanced soft-tissue sarcoma | Yun, Kum-Hee | Yun, KH | 4 | |||||||
| Phase IB/II trial of durvalumab plus doxorubicin combination in patients with advanced soft-tissue sarcoma | Lee, Young Han | Lee, YH | 5 | AAJ-8828-2020 | Park, Young-Jae | |||||
| Phase IB/II trial of durvalumab plus doxorubicin combination in patients with advanced soft-tissue sarcoma | Jun, Hyun Jung | Jun, HJ | 6 | |||||||
| Phase IB/II trial of durvalumab plus doxorubicin combination in patients with advanced soft-tissue sarcoma | Rha, Sun Young | Rha, SY | 7 | |||||||
| Phase IB/II trial of durvalumab plus doxorubicin combination in patients with advanced soft-tissue sarcoma | Kim, Hyo Song | Kim, HS | 8 | D-5568-2011 | Kim, Hyun | |||||
| Phase Ib/IIa randomized study of heterologous ChAdOx1HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB | Tak, Won Young | Tak, WY | 1 | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Daegu, South Korea | tom.evans@barinthusbio.com; | |||||
| Phase Ib/IIa randomized study of heterologous ChAdOx1HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB | Chuang, Wan-Lobg | Chuang, WL | 2 | Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan | C-9536-2009 | Chuang, Wan-Long | 0000-0002-2376-421X | Chuang, Wan-Long | tom.evans@barinthusbio.com; | |
| Phase Ib/IIa randomized study of heterologous ChAdOx1HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB | Chen, Chi-Yi | Chen, CY | 3 | Chia Yi Christian Hosp, Chiayi, Taiwan | KVZ-1550-2024 | Chen, ChiYi | tom.evans@barinthusbio.com; | |||
| Phase Ib/IIa randomized study of heterologous ChAdOx1HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB | Tseng, Kuo-Chih | Tseng, KC | 4 | Dalin Tzu Chi Gen Hosp, Hualien, Taiwan | tom.evans@barinthusbio.com; | |||||
| Phase Ib/IIa randomized study of heterologous ChAdOx1HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB | Lim, Young-Suk | Lim, YS | 5 | Univ Ulsan, Coll Med, Coll Med, Seoul, South Korea | AFQ-5165-2022 | Lim, Young-Suk | 0000-0002-1544-577X | Lim, Young-Suk | tom.evans@barinthusbio.com; | |
| Phase Ib/IIa randomized study of heterologous ChAdOx1HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB | Lo, Gin-Ho | Lo, GH | 6 | E Da Hosp, Kaohsiung, Taiwan | tom.evans@barinthusbio.com; | |||||
| Phase Ib/IIa randomized study of heterologous ChAdOx1HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB | Heo, Jeong | Heo, J | 7 | Pusan Natl Univ, Pusan Natl Univ Hosp, Dept Internal Med, Coll Med, Busan, South Korea | MHQ-1390-2025 | Heo, Jeong | 0000-0003-0961-7851 | Heo, Jeong | tom.evans@barinthusbio.com; | |
| Phase Ib/IIa randomized study of heterologous ChAdOx1HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB | Heo, Jeong | Heo, J | 7 | Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea | MHQ-1390-2025 | Heo, Jeong | 0000-0003-0961-7851 | Heo, Jeong | tom.evans@barinthusbio.com; | |
| Phase Ib/IIa randomized study of heterologous ChAdOx1HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB | Agarwal, Kaushik | Agarwal, K | 8 | Kings Coll Hosp NHS Fdn Trust, Inst Liver Studies, London, England | tom.evans@barinthusbio.com; | |||||
| Phase Ib/IIa randomized study of heterologous ChAdOx1HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB | Bussey, Louise | Bussey, L | 9 | Vaccitech, Harwell, Oxon, South Korea | tom.evans@barinthusbio.com; |
페이지 이동: